Merck Specialities appoints Pratima Reddy as new MD in India Ruchika Sharma1 Aug 2022 5:28 PM ISTNew Delhi: Merck India has recently announced the appointment of Pratima Reddy as the Managing Director for Merck Specialities Pvt. Ltd, the...
Merck Keytruda fails head and neck cancer trial Rahul Verma21 July 2022 5:00 PM ISTMerck, known as MSD outside the United States and Canada, has announced that the Phase 3 KEYNOTE-412 trial evaluating KEYTRUDA (pembrolizumab),...
Merck Keytruda fails in head and neck cancer trial Ruchika Sharma21 July 2022 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Drugmaker Orion sees inflation hit in H2 after quarterly profit beat Ruchika Sharma17 July 2022 9:00 AM ISTNew Delhi: Finnish drugmaker Orion on Friday reported better-than-expected quarterly earnings helped by strong sales of prostate cancer treatment...
Merck, Orion join hands for Investigational Steroid Synthesis Inhibitor ODM-208 to treat Metastatic Castration-Resistant Prostate Cancer Ruchika Sharma14 July 2022 5:00 PM ISTMerck will make an upfront payment to Orion of USD 290 million, which will be expensed by Merck in the third quarter of 2022 and included in non-GAAP...
Merck in advanced talks to buy Seagen in nearly USD 40-billion deal: WSJ Ruchika Sharma10 July 2022 12:00 PM ISTThe companies are seeking to seal the deal on or before the announcement of Merck's second-quarter earnings set for July 28, according to the WSJ...
Merck launches Merck Digital Sciences Studio for healthcare startups Ruchika Sharma3 July 2022 4:00 PM ISTCurrently the program plans to include six startups at each of the Newark, NJ and Cambridge, MA venues.
Merck, Illumina launch research test to unlock deeper insights into tumor genome Ruchika Sharma25 Jun 2022 9:00 AM ISTThe Research Use Only TruSight Oncology 500 HRD test is a next-generation sequencing (NGS)–based assay.
Merck Pneumococcal 15-valent Conjugate Vaccine gets USFDA nod for pediatric use Ruchika Sharma23 Jun 2022 12:45 PM ISTRahway: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (USFDA) has approved an...
Merck presents positive results from Pneumococcal conjugate vaccine study Ruchika Sharma22 Jun 2022 2:30 PM ISTPneumococcal disease is an infection caused by the bacterium Streptococcus pneumoniae, or pneumococcus.
Merck seeks USFDA nod for Keytruda to treat non-small cell lung cancer Ruchika Sharma14 Jun 2022 12:00 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
US FDA directs risk of suicide disclosure on Merck antibaldness pill Propecia Ruchika Sharma12 Jun 2022 10:55 AM ISTNew Delhi: The U.S. health regulators, the USFDA rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the...
